Main Article Content
Abstract
Keywords
Article Details
Authors who publish in the Jurnal Kedokteran dan Kesehatan Indonesia agree to the following terms:
- Authors retain copyright and grant Jurnal Kedokteran dan Kesehatan Indonesia right of first publication with the work simultaneously licensed under a Creative Commons Attribution Licence that allows others to adapt (remix, transform, and build) upon the work non-commercially with an acknowledgement of the work's authorship and initial publication in Jurnal Kedokteran dan Kesehatan Indonesia.
- Authors are permitted to share (copy and redistribute) the journal's published version of the work non-commercially (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in Jurnal Kedokteran dan Kesehatan Indonesia.
References
- García HH, Gonzalez A, Evans C, Gilman R. Cysticercosis Working Group in Peru. Taenia solium cysticerosis. Lancet. 2003;362(9383):547–56.
- Coral-Almeida M, Gabriël S, Abatih EN, Praet N, Benitez W, Dorny P. Taenia solium human cysticercosis: A systematic review of sero-epidemological data from endemic zones around the world. PLoS Neglected Tropical Diseases. 2015;9(7):1–20.
- Zammarchi L, Strohmeyer M, Bartalesi F, Bruno E, Muñoz J, Buonfrate D, et al. Epidemiology and management of cysticercosis and Taenia solium Taeniasis in Europe, systematic review 1990-2011. PLoS One. 2013;8(7): e69537.
- Carpio A, Romo ML. State of the art in neurocysticercosis: Imaging and epidemiology. Asian Pacific Journal of Tropical Medicine . 2016;9(8):821–2.
- Wanda T, Ito A, Swastika K, Dharmawan N, Sako Y, Okamoto M. Taeniases and cysticercosis in Indonesia: Past and present situations. Parasitology. 2013;140(13):1608–16.
- Margono SS, Subahar R, Hamid A, Wandra T, Raka Sudewi SS, Sutisna P, et al. Cysticercosis in Indonesia?: Epidemiological aspects. Southeast Asian Journal of Tropical Medicine Public Health. 2001;32(SUPPL. 2):79–84.
- Susanto I, Ismid IS, Sjarifuddin PK, Sungkar S. Buku ajar parasitologi kedokteran. 4ed . Jakarta: Badan Penerbit FKUI; 2015.
- Garcia HH, Nash TE, Del Brutto OH. Clinical symptoms, diagnosis, and treatment of neurocysticercosis. Lancet Neurology. 2014;13(12):1202–15.
- Carabin H, Ndimubanzi PC, Budke CM, Nguyen H, Qian Y, Cowan LD, et al. Clinical manifestations associated with neurocysticercosis: A systematic review. PLoS Neglected Tropical Diseases. 2011;5(5):e1152.
- Sotelo J. Clinical manifestations, diagnosis, and treatment of neurocysticercosis. Current Neurology and Neuroscience Reports. 2011;11(6):529–35.
- Singhi P, Suthar R. Neurocysticercosis. Indian Journal of Pediatrics. 2015;82(2):166–71.
- Del Brutto OH. Diagnostic criteria for neurocysticercosis, revisited. Pathogens and Global Health [Internet]. 2012;106(5):299–304.
- Sudewi RAA, Sugianto P, Ritarwan K. Infeksi pada sistem saraf. Surabaya: Airlangga University Press; 2011.
- Proaño-Narvaez J V., Meza-Lucas A, Mata-Ruiz O, García-Jerónimo RC, Correa D. Laboratory diagnosis of human neurocysticercosis: Double-blind comparison of enzyme-linked immunosorbent assay and electroimmunotransfer blot assay. Journal of Clinical Microbiology. 2002;40(6):2115–8.
- Dhesi B, Karia SJ, Adab N, Nair S. Imaging in neurocysticercosis. Pract Neurol. 2015;15:135–7.
- Zhao J-L, Lerner A, Shu Z, Gao X-J, Zee C-S. Imaging spectrum of neurocysticercosis. Radiology of Infectious Diseases. 2015;1(2):94–102.
- Jung-Cook H. Pharmacokinetic variability of anthelmintics: implications for the treatment of neurocysticercosis. Expert Review of Clinical Pharmacology. 2012;5(1):21–30.
- Cárdenas G, Carrillo-Mezo R, Jung H, Sciutto E, Hernandez JLS, Fleury A. Subarachnoidal neurocysticercosis non-responsive to cysticidal drugs: A case series. BMC Neurol. 2010;10:16.
- Gripper LB, Welburn SC. Neurocysticercosis infection and disease–A review. Acta Tropica . 2017;166:218–24.
- Chai JY. Praziquantel Treatment in Trematode and Cestode Infections: An Update. Infection and Chemotherapy. 2013;45(1):32–43.
- Brunton LL, Chabner BA KB. Goodman & Gilman’s the pharmacological basis of therapeutics. 12th ed. New York: McGraw-Hill; 2011.
- Matthaiou DK, Panos G, Adamidi ES, Falagas ME. Albendazole versus praziquantel in the treatment of neurocysticercosis: A meta-analysis of comparative trials. PLoS Neglected Tropical Diseases. 2008;2(3):e194.
- Garcia HH, Gonzales I, Lescano AG, Bustos JA, Zimic M, Escalante D et al. Efficacy of combined antiparasitic therapy with praziquantel and albendazole for neurocysticercosis: a double-blind, randomised controlled trial.Lancet Infectious Diseases. 2014;14(8):687–95.
- Carpio A, Kelvin EA, Bagiella E, Leslie D, Leon P, Andrews H, et al. Effects of albendazole treatment on neurocysticercosis: A randomised controlled trial. Journal of Neurology, Neurosurgery, and Psychiatr. 2008;79(9):1050–5.
- Baird RA, Wiebe S, Zunt JR, Halperin JJ, Gronseth G, Roos KL. Evidence-based guideline: Treatment of parenchymal neurocysticercosis: Report of the guideline development subcommittee of the American Academy of Neurology. Neurology. 2013;80(15):1424–9.
- Nash TE, Mahanty S, Garcia HH. Corticosteroid use in neurocysticercosis. Expert Review of Neurotherapeutics. 2011;11(8):1175–83.
References
García HH, Gonzalez A, Evans C, Gilman R. Cysticercosis Working Group in Peru. Taenia solium cysticerosis. Lancet. 2003;362(9383):547–56.
Coral-Almeida M, Gabriël S, Abatih EN, Praet N, Benitez W, Dorny P. Taenia solium human cysticercosis: A systematic review of sero-epidemological data from endemic zones around the world. PLoS Neglected Tropical Diseases. 2015;9(7):1–20.
Zammarchi L, Strohmeyer M, Bartalesi F, Bruno E, Muñoz J, Buonfrate D, et al. Epidemiology and management of cysticercosis and Taenia solium Taeniasis in Europe, systematic review 1990-2011. PLoS One. 2013;8(7): e69537.
Carpio A, Romo ML. State of the art in neurocysticercosis: Imaging and epidemiology. Asian Pacific Journal of Tropical Medicine . 2016;9(8):821–2.
Wanda T, Ito A, Swastika K, Dharmawan N, Sako Y, Okamoto M. Taeniases and cysticercosis in Indonesia: Past and present situations. Parasitology. 2013;140(13):1608–16.
Margono SS, Subahar R, Hamid A, Wandra T, Raka Sudewi SS, Sutisna P, et al. Cysticercosis in Indonesia?: Epidemiological aspects. Southeast Asian Journal of Tropical Medicine Public Health. 2001;32(SUPPL. 2):79–84.
Susanto I, Ismid IS, Sjarifuddin PK, Sungkar S. Buku ajar parasitologi kedokteran. 4ed . Jakarta: Badan Penerbit FKUI; 2015.
Garcia HH, Nash TE, Del Brutto OH. Clinical symptoms, diagnosis, and treatment of neurocysticercosis. Lancet Neurology. 2014;13(12):1202–15.
Carabin H, Ndimubanzi PC, Budke CM, Nguyen H, Qian Y, Cowan LD, et al. Clinical manifestations associated with neurocysticercosis: A systematic review. PLoS Neglected Tropical Diseases. 2011;5(5):e1152.
Sotelo J. Clinical manifestations, diagnosis, and treatment of neurocysticercosis. Current Neurology and Neuroscience Reports. 2011;11(6):529–35.
Singhi P, Suthar R. Neurocysticercosis. Indian Journal of Pediatrics. 2015;82(2):166–71.
Del Brutto OH. Diagnostic criteria for neurocysticercosis, revisited. Pathogens and Global Health [Internet]. 2012;106(5):299–304.
Sudewi RAA, Sugianto P, Ritarwan K. Infeksi pada sistem saraf. Surabaya: Airlangga University Press; 2011.
Proaño-Narvaez J V., Meza-Lucas A, Mata-Ruiz O, García-Jerónimo RC, Correa D. Laboratory diagnosis of human neurocysticercosis: Double-blind comparison of enzyme-linked immunosorbent assay and electroimmunotransfer blot assay. Journal of Clinical Microbiology. 2002;40(6):2115–8.
Dhesi B, Karia SJ, Adab N, Nair S. Imaging in neurocysticercosis. Pract Neurol. 2015;15:135–7.
Zhao J-L, Lerner A, Shu Z, Gao X-J, Zee C-S. Imaging spectrum of neurocysticercosis. Radiology of Infectious Diseases. 2015;1(2):94–102.
Jung-Cook H. Pharmacokinetic variability of anthelmintics: implications for the treatment of neurocysticercosis. Expert Review of Clinical Pharmacology. 2012;5(1):21–30.
Cárdenas G, Carrillo-Mezo R, Jung H, Sciutto E, Hernandez JLS, Fleury A. Subarachnoidal neurocysticercosis non-responsive to cysticidal drugs: A case series. BMC Neurol. 2010;10:16.
Gripper LB, Welburn SC. Neurocysticercosis infection and disease–A review. Acta Tropica . 2017;166:218–24.
Chai JY. Praziquantel Treatment in Trematode and Cestode Infections: An Update. Infection and Chemotherapy. 2013;45(1):32–43.
Brunton LL, Chabner BA KB. Goodman & Gilman’s the pharmacological basis of therapeutics. 12th ed. New York: McGraw-Hill; 2011.
Matthaiou DK, Panos G, Adamidi ES, Falagas ME. Albendazole versus praziquantel in the treatment of neurocysticercosis: A meta-analysis of comparative trials. PLoS Neglected Tropical Diseases. 2008;2(3):e194.
Garcia HH, Gonzales I, Lescano AG, Bustos JA, Zimic M, Escalante D et al. Efficacy of combined antiparasitic therapy with praziquantel and albendazole for neurocysticercosis: a double-blind, randomised controlled trial.Lancet Infectious Diseases. 2014;14(8):687–95.
Carpio A, Kelvin EA, Bagiella E, Leslie D, Leon P, Andrews H, et al. Effects of albendazole treatment on neurocysticercosis: A randomised controlled trial. Journal of Neurology, Neurosurgery, and Psychiatr. 2008;79(9):1050–5.
Baird RA, Wiebe S, Zunt JR, Halperin JJ, Gronseth G, Roos KL. Evidence-based guideline: Treatment of parenchymal neurocysticercosis: Report of the guideline development subcommittee of the American Academy of Neurology. Neurology. 2013;80(15):1424–9.
Nash TE, Mahanty S, Garcia HH. Corticosteroid use in neurocysticercosis. Expert Review of Neurotherapeutics. 2011;11(8):1175–83.